Medicines R Us Ltd
Medicines R Us Ltd
Registered Number
(England and Wales)
Unaudited Financial Statements for the Year ended
31 May 2023
Medicines R Us LtdCompany Information
for the year from 1 June 2022 to 31 May 2023
for the year from 1 June 2022 to 31 May 2023
Directors | |
Registered Address | |
Registered Number |
Medicines R Us LtdBalance Sheet as at
31 May 2023
31 May 2023
Notes | 2023 | 2022 | ||||||
|---|---|---|---|---|---|---|---|---|
£ | £ | £ | £ | |||||
| Fixed assets | ||||||||
| Tangible assets | 5 | |||||||
| Current assets | ||||||||
| Stocks | ||||||||
| Debtors | 8 | |||||||
| Cash at bank and on hand | ||||||||
| Creditors amounts falling due within one year | 9 | |||||||
| Net current assets (liabilities) | ||||||||
| Total assets less current liabilities | ||||||||
| Net assets | ||||||||
| Capital and reserves | ||||||||
| Called up share capital | ||||||||
| Profit and loss account | ||||||||
| Shareholders' funds | ||||||||
The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.
| The financial statements were approved and authorised for issue by the Board of Directors on 22 December 2023, and are signed on its behalf by: |
Director Registered Company No. 07258925 |
Medicines R Us LtdNotes to the Financial Statements
for the year ended 31 May 2023
for the year ended 31 May 2023
| 1. | Statutory information |
|---|---|
| 2. | Basis of measurement used in financial statements |
|---|---|
| 3. | Accounting policies |
|---|
| Turnover policy | |
|---|---|
| Property, plant and equipment policy | |
|---|---|
| Reducing balance (%) | ||
|---|---|---|
| Plant and machinery | ||
| Fixtures and fittings |
| Stocks policy | |
|---|---|
| Taxation policy | |
|---|---|
| Employee benefits policy | |
|---|---|
| 4. | Employee information |
|---|---|
| 2023 | 2022 | |||
|---|---|---|---|---|
| Average number of employees during the year |
| 5. | Property, plant and equipment |
|---|---|
Vehicles | Fixtures & fittings | Office Equipment | Total | |||||
|---|---|---|---|---|---|---|---|---|
| £ | £ | £ | £ | |||||
| Cost or valuation | ||||||||
| At 01 June 22 | ||||||||
| Additions | ||||||||
| At 31 May 23 | ||||||||
| Depreciation and impairment | ||||||||
| At 01 June 22 | ||||||||
| Charge for year | ||||||||
| At 31 May 23 | ||||||||
| Net book value | ||||||||
| At 31 May 23 | ||||||||
| At 31 May 22 |
| 6. | Description of nature of transactions and balances with related parties |
|---|---|
| 7. | Dividends proposed and payable |
|---|---|
2023 | 2022 | |||
|---|---|---|---|---|
| £ | £ | |||
| Dividends Paid | ||||
| Total |
| 8. | Debtors |
|---|---|
2023 | 2022 | |||
|---|---|---|---|---|
| £ | £ | |||
| Trade debtors / trade receivables | ||||
| Amounts owed by group undertakings | ||||
| Other debtors | ||||
| Prepayments and accrued income | ||||
| Total |
| 9. | Creditors within one year |
|---|---|
2023 | 2022 | |||
|---|---|---|---|---|
| £ | £ | |||
| Trade creditors / trade payables | ||||
| Amounts owed to related parties | ||||
| Taxation and social security | ||||
| Other creditors | ||||
| Accrued liabilities and deferred income | ||||
| Total |